Pharmaceutical giant Pfizer is reported to be close to selling its $1.9 billion annual turnover infant nutrition business to Nestle for between $9 billion and $10 billion. With roughly 80%
Pharmaceutical giant Pfizer is reported to be close to selling its $1.9 billion annual turnover infant nutrition business to Nestle for between $9 billion and $10 billion. With roughly 80%